Achillion to Present at the Leerink Partners 6th Annual Global Healthcare Conference
February 13 2017 - 6:05AM
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN)
announced today that Milind Deshpande, Ph.D., President and Chief
Executive Officer of Achillion, will present a corporate overview
at the Leerink Partners 6th Annual Global Healthcare Conference on
Thursday, February 16, 2017, at 1:30 p.m. ET at the Lotte New York
Palace Hotel in New York, NY.
The live audio and subsequent archived webcasts
of the Company's presentations will be accessible from the
Company's investor relations website, http://ir.achillion.com. The
audio recording will be archived for 30 days following the live
presentation. Please connect to Achillion's website several minutes
prior to the start of the presentation to ensure adequate time for
any software downloads that may be necessary.
About Achillion
Pharmaceuticals
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is
a science-driven, patient-focused company seeking to leverage its
strengths across the continuum from discovery to commercialization
in its goal of providing better treatments for people with serious
diseases. The company employs a highly-disciplined discovery and
development approach that has allowed it to pursue best-in-class
oral antiviral therapy for chronic hepatitis C (HCV) and build a
platform of potent and specific complement inhibitors. Achillion is
rapidly advancing its efforts to become a fully-integrated
pharmaceutical company with a goal of bringing life-saving
medicines to patients with rare diseases. More information is
available at http://www.achillion.com.
Investors:
Glenn Schulman
Achillion Pharmaceuticals, Inc.
Tel. (203) 752-5510
gschulman@achillion.com
Media:
Liz Power
Achillion Pharmaceuticals, Inc.
Tel: (203) 752-5509
lpower@achillion.com
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Sep 2023 to Sep 2024